• Japanese Medical Team Discovers Gut Microbiota to Diagnose and Treat Dementia with Lewy Bodies

    Mar 23 | Diagnostics World News | A research team from the Nagoya University Graduate School of Medicine, Japan, discovered three gut bacteria types that may lead to predicting and treating dementia with Lewy bodies. More

  • Lupus Patients Can Expect At-Home Test For Kidney Inflammation

    Mar 22 | Diagnostics World News | A smartphone-based app and test kit for lupus nephritis may start making its way to neighborhood CVS and Walgreens stores in another few years. The urine test has been shown to detect the protein ALCAM (activated leukocyte cell adhesion molecule) to distinguish lupus patients with and without the condition with 86% accuracy in multiple cohorts. More

  • Coronary Heart Disease Can Now Be Detected Early In The Blood

    Mar 21 | Diagnostics World News | The worlds of genetics, epigenetics, and artificial intelligence have united to enable development of a blood test for the early detection of coronary heart disease. Newly launched in the U.S. by Cardio Diagnostics, PrecisionCHD is underpinned by the same technology as the company’s predecessor Epi+Gen CHD risk assessment test but using a different set of genetic and DNA methylation biomarkers. More

  • MRD in 2023: Current Capabilities, Differing Approaches, and Tests on the Horizon

    Mar 16 | Diagnostics World News | An array of diagnostics companies have set their sights on developing minimal residual disease tests capable of detecting low levels of cancer cells remaining in the body following surgery or other types of treatment. The aim is to help measure response to therapy and identify patients at risk of relapse. More

  • New Telomere Measuring Method Addressing Limitations Of Current Options

    Mar 14 | Diagnostics World News | A research collaboration led by led by Duke-NUS Medical School and National Heart Centre Singapore has set the stage for telomere measurement to one day be added to the list of clinical-grade methods for assessing biological aging. The focus is on rapid and precise measurement of individual telomeres using a technique that employs “telobaits” that latch onto the ends of telomeres in large pools of DNA fragments. More

  • Craig Venter on Genomics’ Past and Precision Medicine’s Future

    Mar 09 | Diagnostics World News | Kevin Davies and Craig Venter sat down together to celebrate thirty years of the Molecular and Precision Med Tri-Con this week in San Diego on Monday night. Davies—the founding editor of Bio-IT World—gave a guided tour of human genomic research and sequencing since 1991 with Venter offering first person color commentary along the way. More

  • Illumina, Myriad Partner To Release HRD Test

    Mar 08 | Diagnostics World News | Illumina’s TruSight Oncology 500 HRD, a research-use-only oncology homologous recombination deficiency test, is now available in the US thanks to an expanded partnership between Illumina and Myriad Genetics. The expanded partnership also establishes a unique companion diagnostic alliance for the pharmaceutical industry, which will enable more clinical research for gene-based, targeted therapies. More

  • Pharma-Diagnostics Lockstep: How Two Industries Can Work Together for Precision Medicine

    Mar 07 | Diagnostics World News | Sarah Hersey, VP of Precision Medicine at Bristol Myers Squibb, gave a balanced view of the challenges and opportunities facing precision medicine in her keynote address at the Molecular & Precision Medicine Tri-Conference in San Diego this week. After her presentation she was joined by others in the space to talk about the future for diagnostics and precision medicine. More

  • Bacteria-Grown Nanowires Detect Analytes Wafting By in Air

    Mar 02 | Diagnostics World News | Researchers at University of Massachusetts, Amherst, have created bacteria-generated sensing devices capable of identifying real-time changes in various chemical concentrations. More

  • Digital Health Technologies Gaining Ground In Clinical Trials

    Mar 01 | Diagnostics World News | Growing interest in the use and utility of digital health technologies (DHTs) was on full display at the recent Summit for Clinical Ops Executives. While outsourcing professionals were learning from Merck’s experience in evaluating and selecting DHT suppliers, digital data specialists were getting a progress update on a study comparing sensor-based symptom measures with traditional clinician-rated assessments in patients with early, untreated Parkinson’s Disease. More
View more articles

 
DXX-Industry-spotlight

bioready-citrate-gold-nanoshells


BioReady Citrate Gold Nanoshells

If you are looking for a probe that offers increased sensitivity, lower antibody usage, and the convenience of passive conjugation, you’ve come to the right place. Introducing BioReady Citrate Gold Nanoshells, enabling enhanced sensitivity for your lateral flow assay.

Learn more